[Durgical](https://durgical.com/en/) › [DurgiPedia](https://durgical.com/en/durgipedia/) › [Epidemiology](https://durgical.com/en/epidemiology/) › [Diagnostic tests](https://durgical.com/en/epidemiology/areas/diagnostic/) › Test and treatment thresholds

# Test and treatment thresholds

- Concept

Doctors never reach certainty, so they need a rule for when doubt is small enough to stop, to test or to treat. The threshold model is that rule.

Updated Nov 19, 2026

## Key points

- Three zones: below the test threshold do nothing; between the thresholds test; above the test-treatment threshold treat.
- Treatment threshold = H / (H + B) = 1 / (1 + B/H), with B the net benefit and H the net harm of treating.
- Large benefit and small harm put the line low; a toxic treatment for a mild disease puts it high.
- Test accuracy and test risk set how wide the testing zone is, not where the treatment threshold sits.
- Patient values move the lines: if the treatment's harm matters more to this patient, they rise.

On this page

- The basics Key points
- What it is
- How to think about it
- Key facts
- Worked example
- What moves the lines
- In practice
- Common pitfalls
- Common traps
- Elsewhere in DurgiPedia

- Study Test yourself

- Connections Connections

## What it is

The threshold model puts the probability of disease on a line from 0 to 100% with two cut points. Below the test threshold neither testing nor treatment is worthwhile; above the test-treatment threshold treatment starts without testing; in between, a test is done and its result decides.

## How to think about it

The treatment threshold is the balance point where treating and not treating are equally good bets: the more a treatment helps the sick compared with how much it hurts the healthy, the lower that point sits. The test zone is the stretch around it that a test can reach across; a strong, safe test stretches it wide, a weak or risky test shrinks it.

## Key facts

- The model was described by Pauker and Kassirer in 1980 and is still the backbone of testing pathways.
- B = gain from treating a patient who has the disease; H = loss from treating one who does not.
- Order of the lines: test threshold
- Made-up disease: treating a sick patient gains B = 9 points; treating a healthy one costs H = 1 point.
- Treatment threshold = H / (H + B) = 1 / 10 = 10%: above 10%, treating beats not treating.
- Made-up harmless test: LR+ 9, LR− 0.1. At the 10% line the odds are 0.1 / 0.9 ≈ 0.111.
- Test threshold: where a positive just reaches 10%: odds 0.111 / 9 ≈ 0.012, about 1.2%.
- Test-treatment threshold: where a negative just falls to 10%: odds 0.111 / 0.1 ≈ 1.11, about 53%.
- Zones: below 1.2% do nothing; 1.2–53% test and follow the result; above 53% treat without testing.
- Weaker test, LR+ 3 and LR− 0.3: 0.111 / 3 = 0.037 (3.6%) and 0.111 / 0.3 = 0.37 (27%). The zone shrinks to 3.6–27%.
- Harsher treatment, H = 3: line = 3 / 12 = 25%, odds 0.333. With the first test the zone moves to 3.6–77%.
- Reading: benefit and harm place the treatment line; the test's strength sets how far either side of it testing pays.

## What moves the lines

| Change | Treatment threshold | Testing zone | Example |
| --- | --- | --- | --- |
| Treatment more harmful | Rises | Shifts up | Anticoagulation in a patient with a high bleeding risk: all thresholds rise |
| Untreated disease more dangerous, treatment more effective | Falls | Shifts down | Suspected tuberculosis: treatment worthwhile from about 3% |
| Test more accurate | No change | Widens | A test with higher LR+ and lower LR− can settle more patients |
| Test riskier or more costly | No change | Narrows (the test threshold rises) | CT pulmonary angiography: radiation and contrast; low-probability, PERC-negative patients are not tested |
| Test fast, cheap and specific | No change | Starts lower | A rapid streptococcal antigen test lowers the test threshold for sore throat |
| Patient fears the treatment's harm more | Rises | Shifts up | Patient values enter as the weight given to harm against benefit |

## In practice

- [Pulmonary embolism](https://durgical.com/en/conditions/pulmonary-embolism/): the test threshold has been put near 2%; a low-probability patient who meets all PERC criteria is below it and is not tested.
- Pulmonary embolism: low or intermediate probability goes to D-dimer, high probability straight to CT pulmonary angiography (the testing zone).
- Pharyngitis: in a vignette study, GPs set the test threshold near 16% and the treatment threshold near 88%; a quick specific antigen test keeps the test threshold low.
- Appendicitis: in the same study the thresholds were about 52% (test) and 69% (treat); the Alvarado score (appendicitis) and the McIsaac score (pharyngitis) set the probability.
- Most errors are in the probability, not the line: GPs underestimated appendicitis and overestimated [streptococcal pharyngitis](https://durgical.com/en/conditions/streptococcal-pharyngitis/); in a bacteriuria vignette most clinicians overestimated infection and would treat.

## Common pitfalls

- Using 50% as the treatment line by habit instead of weighing benefit against harm.
- Testing patients below the test threshold, where false positives and test harms outweigh the few cases found.
- Testing patients above the test-treatment threshold, where even a negative would not stop treatment.
- Reusing a published threshold for a patient whose bleeding risk or values differ from the study's.

## Common traps

- **The treatment threshold is 50%**: it is H / (H + B); a safe treatment for a dangerous disease is right at a few percent (about 2.7% for suspected tuberculosis in one analysis)
- **Treating without certainty is a mistake**: above the treatment threshold treating is the better bet even though some treated patients turn out not to have the disease
- **A better test lowers the treatment threshold**: test accuracy only widens the testing zone; the treatment threshold depends on benefit, harm and the patient's values
- **A low probability calls for a test to be sure**: below the test threshold a test finds few cases and its false positives and risks do more harm than good
- **Overtreatment means the thresholds are wrong**: often the line is sensible and the probability estimate is too high, as in the bacteriuria vignette where most clinicians would treat

## Test yourself

Think of the answer, then tap the question to see it.

## Treating a sick patient gains 4 points and treating a healthy one costs 1 point. What is the treatment threshold?

H / (H + B) = 1 / 5 = 20%: above 20%, treating is the better bet.

## Why can the treatment threshold for suspected tuberculosis sit near 3%?

The benefit of treating a true case is large compared with the harm of treating a non-case (ratio about 36 in one analysis), so 1 / (1 + 36) ≈ 2.7%.

## A new test is safer and more accurate than the old one. Which threshold does not move, and what happens to the others?

The treatment threshold stays: it depends on benefit, harm and values. The testing zone widens: the test threshold falls and the test-treatment threshold rises.

## A low-probability patient with suspected pulmonary embolism meets all PERC criteria. Why not order a D-dimer anyway?

The probability is already below the test threshold (about 2%): false positives leading to CT, with radiation and contrast, would outweigh the few emboli found.

## A patient's bleeding risk is high. What happens to the probability at which anticoagulation becomes worthwhile?

It rises: more harm (H) raises H / (H + B), so more certainty is needed before treating, and the testing zone shifts up with it.

[Add to my cards (5)](https://durgical.app/estudiar/?add=/en/epidemiology/test-and-treatment-thresholds/)

## Elsewhere in DurgiPedia

- [Suspected pulmonary embolism: probability first, then the test](https://durgical.com/en/emergency-medicine/suspected-pulmonary-embolism-probability-first-then-the-test/)
- [Approach to sore throat: Centor and McIsaac](https://durgical.com/en/ent/approach-to-sore-throat-centor-and-mcisaac/)
- [Imaging in suspected appendicitis](https://durgical.com/en/radiology/imaging-in-suspected-appendicitis/)

## Connections

## Related 6

- [Pre-test and post-test probability](https://durgical.com/en/epidemiology/pre-test-and-post-test-probability/)
- [Likelihood ratios](https://durgical.com/en/epidemiology/likelihood-ratios/)
- [Choosing a cutoff: sensitivity vs specificity](https://durgical.com/en/epidemiology/choosing-a-cutoff-sensitivity-vs-specificity/)
- [Serial and parallel testing](https://durgical.com/en/epidemiology/serial-and-parallel-testing/)
- [Decision analysis and decision trees](https://durgical.com/en/epidemiology/decision-analysis-and-decision-trees/)
- [Number needed to treat](https://durgical.com/en/epidemiology/number-needed-to-treat/)

## Related conditions 3

- [Pulmonary embolism](https://durgical.com/en/conditions/pulmonary-embolism/)
- [Streptococcal pharyngitis](https://durgical.com/en/conditions/streptococcal-pharyngitis/)
- [Acute appendicitis](https://durgical.com/en/conditions/acute-appendicitis/)

[← All of epidemiology](https://durgical.com/en/epidemiology/)

Educational content on epidemiological and statistical methods; the examples use made-up numbers to teach the calculation. Not a clinical or legal guide: current Colombian rules are in the official sources.

Sources: [The threshold model revisited](https://europepmc.org/article/PMC/PMC6590161) (Journal of Evaluation in Clinical Practice, 2019); [Decision theoretical foundations of clinical practice guidelines: an extension of the ASH thrombophilia guidelines](https://europepmc.org/article/PMC/PMC11319831) (Blood Advances, 2024); [Rational decision making in medicine: Implications for overuse and underuse](https://europepmc.org/article/PMC/PMC6001794) (Journal of Evaluation in Clinical Practice, 2018); [Correlation of clinical decision-making with probability of disease: A web-based study among general practitioners](https://europepmc.org/article/PMC/PMC7595298) (PLoS ONE, 2020); [Pulmonary embolism: the diagnosis, risk-stratification, treatment and disposition of emergency department patients](https://europepmc.org/article/PMC/PMC5065342) (Clinical and Experimental Emergency Medicine, 2016); [Clinician Testing and Treatment Thresholds for Management of Urinary Tract Infection](https://europepmc.org/article/PMC/PMC10500043) (Open Forum Infectious Diseases, 2023).

## **Spotted a mistake?** We are always improving for the community. Tell us what is wrong and our team will review it. Report a mistake

Representative model, for educational purposes only.

---
Source: https://durgical.com/en/epidemiology/test-and-treatment-thresholds/
License: CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). Cite as: DurgiPedia (durgical.com), https://durgical.com/en/epidemiology/test-and-treatment-thresholds/
